PZAT is a member of the Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC) consortium that aims to help women prevent HIV infection by accelerating the introduction and scale-up of new and emerging biomedical prevention products. Currently, as part of the MOSAIC work, Pangaea through the Catalyzing access to new prevention products to stop HIV (CATALYST) study is collaborating with the Ministry of Health and Child Care, Civil Society, Advocates, and implementing partners to generate, synthesize, and promote evidence needed by decision-makers to strengthen existing PrEP service delivery platforms and facilitate the introduction of new PrEP products aligned with the needs and preferences of women, particularly Adolescent Girls and Young Women (AGYW), transgender populations, Pregnant and Breastfeeding Populations (PBFP), and Female Sex Workers (FSW).